跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 85 条关于
“Blackrock Neurotech”
全部
85
临床试验
31
药物
8
机构
4
资讯
42
5个月前
CorTec Receives FDA Breakthrough Device Designation for Brain-Computer Interface in Stroke Rehabilitation
10个月前
Synchron Secures $200M Series D to Commercialize Brain-Computer Interface Platform
去年
InhaleRx's IRX-211 Receives Approval for Phase II Breakthrough Cancer Pain Trial; Neurotech's NTI164 Shows Promise in PANDAS/PANS
去年
Neurotech International Advances NTI164 Drug Trials with Ethics Approval for Pharmacokinetic Study
去年
Neurotech International's NTI164 Shows Promise in Pediatric Neurological Disorders
2年前
FDA Extends Review of Neurotech's NT-501 for Macular Telangiectasia Type 2
去年
UNEEG Medical's Subcutaneous EEG Implant System Receives FDA Breakthrough Device Designation for Epilepsy Monitoring
去年
Neurotech Receives Approval to Commence Human Pharmacokinetic Study of NTI164
4个月前
Motif Neurotech Receives FDA Approval for First Clinical Trial of Wireless Brain Implant for Treatment-Resistant Depression
去年
FDA Extends Review of Neurotech's NT-501 for Macular Telangiectasia Type 2
第 1 页,共 5 页
上一页
下一页